Manganese and its compounds

These substances were identified for action under the Chemicals Management Plan (CMP). The draft assessment focuses on the manganese moiety and therefore considers manganese in its elemental form, manganese substances, and manganese released in dissolved or particulate form. As such, the draft assessment considers all manganese-containing substances beyond the 11 identified as priorities for assessment, listed in the table below.

Summary of publications

Substance group CAS RN DSL or R-ICL name Common name (abbreviation) Draft assessment Risk management scope Proposed conclusion on section 64 criteria Follow-up activities
Manganese and its compounds 1313-13-9 Manganese oxide Manganese dioxide HTML HTML Meets one or more of the criteria Refer to risk management scope
1335-36-0 1,2,3-Propanetriol, mono(dihydrogen phosphate), manganese salt Manganese glycerophosphate
1344-43-0 Manganese oxide Manganese oxide
7439-96-5 Manganese Elemental manganese
10101-66-3 Diphosphoric acid, ammonium manganese (3+) salt (1:1:1) Ammonium manganese pyrophosphate/ Manganese violet
12108-13-3 Manganese, tricarbonyl[(1,2,3,4,5-<C)-1-methyl-2,4-cyclopentadien-1-yl]- Methylcyclopentadienyl manganese tricarbonyl (MMT)
18820-29-6 Manganese sulfide Manganese sulfide
29193-02-0 L-Proline, 5-oxo-, manganese salt (1:?) Manganese pyroglutamate
35355-77-2 C.I. Pigment Red 63:2 C.I. Pigment Red 63:2
68551-42-8 Fatty acids, C6-19-branched, manganese salts Manganous (C6-C19) branched alkanoate
105883-50-9 Manganese, bis[N-(acetyl-.Κ.O)-L-methioninato-.Κ.O]- Manganese acetyl methionate

Timelines

Date Activity
October 2026 Anticipated publication of the final assessment and the proposed risk management approach.
October 25, 2025 Publication and start of 60-day public comment period on the draft assessment and risk management scope. The related notice was published in the Canada Gazette, Part I: Vol. 159, No. 43.

Page details

2025-10-24